Call from Friday December 19th, featuring Dr. Anne Yacoub.

Anne Damian Yacoub, M.D., is a neurologist who specializes in both multiple sclerosis and headache. Her areas of expertise include the diagnosis and treatment of multiple sclerosis and other neuroimmunological disorders that involve the central nervous system. She is also an expert in acute and chronic management of headache disorders.

Dr. Yacoub earned her medical degree from the University of Arizona College of Medicine, followed by a residency in neurology at the McGill University Health Centre. Dr. Yacoub spent one year studying the diagnosis and management of headaches as a Seymour Diamond Headache Medicine fellow in a combined program at the Diamond Headache Clinic and the Loyola University Medical Center in Chicago. She subsequently trained as a clinical and research fellow in the Johns Hopkins Department of Neurology, studying neuroimmunology and neurological infections.

Dr. Yacoub's research interests include studying migraine headaches in patients with multiple sclerosis.

Call from Friday December 12th, featuring Dr. Michael Streiff.

Dr. Streiff's major clinical interest involves the prevention and treatment of venous thromboembolism. He has written several comprehensive reviews on vena caval filters and the management of venous thromboembolism in cancer patients. He chairs the Venous Thromboembolism Guideline Committee for the National Comprehensive Cancer Center Network and has served on international consensus panels to develop standardized guidelines for the use of vena caval filters in the management of venous thromboembolism. As a member of a Johns Hopkins Evidence-Based Practice Center panel, he participated in the development of evidence reports on the management of venous thromboembolism.

As Medical Director of the Anticoagulation Management Service and Outpatient Clinics, he and his colleagues from the Department of Pharmacy have been actively involved in developing policies and procedures for standardizing anticoagulation management and guidelines for VTE prevention at the Johns Hopkins Medical Institutions. As the consulting Hematologist for the Johns Hopkins Comprehensive Hemophilia Treatment Center, he is actively involved in the diagnosis and treatment of patients with hemophilia, von Willebrand disease and other hemostatic disorders.

Call from Friday December 5th, 2025 featuring Dr. Otis Brawley.

Otis Brawley is a globally-recognized expert in cancer prevention and control. He has worked to reduce overscreening of medical conditions, which has revolutionized patient treatment by increasing quality of life and reducing health disparities.

Brawley's research focuses on developing cancer screening strategies and ensuring their effectiveness. He has championed efforts to decrease smoking and implement other lifestyle risk reduction programs, as well as to provide critical support to cancer patients and concentrate cancer control efforts in areas where they could be most effective. Brawley currently leads a broad interdisciplinary research effort on cancer health disparities at the Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, striving to close racial, economic, and social disparities in the prevention, detection, and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland.

This week we have a throwback episode due to the Holiday.
This call is from August 2024, lead by our host Dr. G.

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins.

Call from Friday November 21st, featuring a very special guest, former NFL Pro-Bowl Linebacker Art Still!

Art Still is one of the greatest defensive ends in University of Kentucky history, and built a remarkable 12-year NFL career, including an amazing run with the Kansas City Chiefs. Yet today, football is only part of his story.

In 2023 he was diagnosed with ATTR amyloidosis, a rare hereditary disease caused by the buildup of amyloid proteins that can impair major organs, often affecting the nerves, heart, and kidneys. Now Still is using his platform to raise awareness and advocate for early detection and treatment of this condition.

Call from Friday November 7th, featuring Dr. Katie Shaw.

Katherine Shaw, M.D., practices internal medicine and pediatrics at East Baltimore Medical Center. She received her medical degree from Vanderbilt University School of Medicine, and completed her residency in pediatrics at Johns Hopkins University School of Medicine. Dr. Shaw is board-certified in internal medicine and pediatrics.

Call from Friday November 7th, featuring Dr. Todd Wolynn.

Dr, Wolynn received his Medical Degree from the University of Pittsburgh School of Medicine in Pennsylvania and earned his Master of Medical Management from Carnegie Mellon University. He is CEO of Kids Plus Pediatrics an independent pediatric practice in Pittsburgh, PA with three locations and 20 providers. His areas of expertise include: practice management, breastfeeding medicine, sleep medicine, medical communication, vaccine advocacy and healthcare media engagement.

In the past few years Dr. Wolynn's focus has been on: healthcare quality, social determinants of health and mental health support in the primary care setting, and confronting vaccine disinformation and weaponized anti-vaccine social media attacks. He cofounded Shots Heard Round the World (www.ShotsHeard.org) which is now operated by the Public Good Projects a non-profit supporting 'the science and art of communication for change'. Dr. Wolynn is also Board President of Trying Together, a non-profit which supports 'the work of early childhood'.

Call from Friday October 31st, featuring Dr. Kelly Mills.

As the director of the Johns Hopkins Movement Disorders Division, Dr. Kelly Mills cares for patients who have movement disorders such as Parkinson's disease, atypical parkinsonism, dystonia, ataxia, tremor and Huntington's disease. He also evaluates and manages patients needing deep brain stimulation to manage their movement symptoms and provides botulinum toxin treatment for various disorders.

In his research, Dr. Mills explores the cognitive dysfunction that can occur in movement disorders such as Parkinson's disease. He is particularly interested in describing the role of the basal ganglia in cognition, especially in the context of various diseases that can affect this structure.

His work focuses on clarifying how certain treatments might impact cognitive and psychiatric problems. For instance, Dr. Mills studies how deep brain stimulation, when used to treat movement symptoms, can impact cognitive function such as attention, memory or impulsivity.